Alfonso Jesús
Domínguez-Gil Hurlé
Profesor Emérito Honorífico
Universidad Austral de Chile
Valdivia, ChilePublicacions en col·laboració amb investigadors/es de Universidad Austral de Chile (8)
2016
-
Gene–gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients
Drug Metabolism and Pharmacokinetics, Vol. 31, Núm. 5, pp. 349-355
-
Influence of the number of daily pills and doses on adherence to antiretroviral treatment: A 7-year study
Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 1, pp. 34-39
2014
-
Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients
Personalized Medicine, Vol. 11, Núm. 7, pp. 693-704
2013
-
Impact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: A 5-year study
Patient Preference and Adherence, Vol. 7, pp. 729-739
-
Nuevas estrategias en la optimización posológica de lopinavir/ritonavir en pacientes infectados por el virus de la inmunodeficiencia humana
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 1, pp. 36-43
2011
-
Population pharmacokinetic/pharmacogenetic model for optimization of Efavirenz therapy in caucasian HIV-infected patients
Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 11, pp. 5314-5324
2009
-
Hyperhidrosis in association with efavirenz
AIDS Patient Care and STDs, Vol. 23, Núm. 3, pp. 143-145
-
Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients
Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 7, pp. 2791-2798